Colchicine in acute coronary syndromes: the present and the possible future

Imazio, M. & Nidorf, M. Colchicine and the heart. Eur. Heart J. 42, 2745–2760 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Imazio, M. et al. Colchicine for the treatment of the spectrum of cardiovascular diseases: current evidence and ongoing perspectives. J. Cardiovasc. Med. (Hagerstown) 25, 653–663 (2024).

Article  CAS  PubMed  Google Scholar 

Ridker, P. M. et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N. Engl. J. Med. 377, 1119–1131 (2017).

Article  CAS  PubMed  Google Scholar 

Nidorf, S. M., Eikelboom, J. W., Budgeon, C. A. & Thompson, P. L. Low-dose colchicine for secondary prevention of cardiovascular disease. J. Am. Coll. Cardiol. 61, 404–410 (2013).

Article  CAS  PubMed  Google Scholar 

Nidorf, S. M. et al. Colchicine in patients with chronic coronary disease. N. Engl. J. Med. 383, 1838–1847 (2020).

Article  CAS  PubMed  Google Scholar 

Tardif, J. C. et al. Efficacy and safety of low-dose colchicine after myocardial infarction. N. Engl. J. Med. 381, 2497–2505 (2019).

Article  CAS  PubMed  Google Scholar 

Visseren, F. L. J. et al. 2021 ESC guidelines on cardiovascular disease prevention in clinical practice. Eur. Heart J. 42, 3227–3337 (2021).

Article  PubMed  Google Scholar 

Vrints, C. et al. 2024 ESC guidelines for the management of chronic coronary syndromes. Eur. Heart J. 45, 3415–3537 (2024).

Article  CAS  PubMed  Google Scholar 

Jolly, S. S. et al. Colchicine in acute myocardial infarction. N. Engl. J. Med. (2024).

Tong, D. C. et al. Colchicine in patients with acute coronary syndrome: two-year follow-up of the Australian COPS randomized clinical trial. Circulation 144, 1584–1586 (2021).

Article  PubMed  Google Scholar 

留言 (0)

沒有登入
gif